![]() Idorsia Idorsia, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs. | ||
Founding Date | Founding Date 1929 | Founding Date 2017 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Boulogne-Billancourt, FR HQ Algiers, DZ South Yarra, AU Wien, AT Merelbeke, BE São Paulo, BR Mississauga, CA see more | Locations Allschwil, CH HQ Shanghai, CN Lörrach, DE Chiyoda City, JP |
Employees | Employees 5,358 | Employees 8007% increase |
Financial | ||
Revenue (est.) | Revenue (est.) €3.7b (FY, 2025) | Revenue (est.) CHF220.6m (FY, 2025) |
Cost of goods | Cost of goods €659.1m (FY, 2025) | Cost of goods CHF20.9m (FY, 2025) |
Gross profit | Gross profit €3.3b (FY, 2025) | Gross profit CHF214.3m (FY, 2025) |
Net income | Net income €445.1m (FY, 2025) | Net income (CHF111.7m) (FY, 2025) |

Idorsia, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs.
View company